EVALUATION OF THE EFFECTIVENESS OF A 7% ACCELERATED HYDROGEN PEROXIDE-BASED FORMULATION AGAINST CANINE PARVOVIRUS

Similar documents
A Product based on accelerated and stabilized hydrogen peroxide:

Transfection of Sf9 cells with recombinant Bacmid DNA

Role of Interferon in the Propagation of MM Virus in L Cells

RODENT Hepatocytes Care Manual

Quantitative Assay of Paravaccinia Virus Based

Adenovirus Manual 1. Table of Contents. Large Scale Prep 2. Quick MOI Test 4. Infection of MNT-1 Cells 8. Adenovirus Stocks 9

GLP VIRUCIDAL TESTING OF ZEROMOLD PLUS FOR HIV-1

Test Report. Efficacy of A New JM Nanocomposite Material in Inhibiting Respiratory Syncytial Virus Cellular Infection

Protocol for Thawing Cryopreserved Hepatocytes

BacPAK Baculovirus Rapid Titer Kit

N Report IPL : MA on Influenza virus type A-H1N1. Customer : OXY PHARM 917 rue Marcel Paul ZA des Grands Godets Champigny sur Marne

Clinell Universal Wipes Batch number Client

To place an order, please visit lifelinecelltech.com or call customer service at

The Microbiology and Virology Laboratory. Volume --- FINAL REPORT VIRUCIDAL EFFICACY TEST USING SWINE INFLUENZA A VIRUS (H1N1) Test Agent Anolyte

Efficacy of Common Disinfectant/Cleaning Agents in Inactivating Murine Norovirus as a Surrogate for Human Norovirus

Chang Gung University co-commissioned final report. Research Ttitle: Antiviral mechanism study for 254 UVC robot system

Environmental Surface

PROTOCOL: OPTIMIZATION OF LENTIVIRAL TRANSDUCTION USING SPINFECTION

New Method for Evaluation of Virucidal Activity of Antiseptics and Disinfectants

Defective Interfering Particles of Respiratory Syncytial Virus

Product Use HPSC-CC are for research use only. It is not approved for human or animal use, or for application in in vitro diagnostic procedures.

Norovirus Surrogate Test Exposure to SixLog s ihp TM (ionized Hydrogen Peroxide) Decontamination Technology. Executive Summary:

Thawing MEFs (Mouse Embryonic Fibroblasts (MEFs)

Study N 286V AGRI GERM /14

LentiBoost Lentiviral Transduction Enhancer

Protocol for Thawing and Use of Plateable and Suspension Cryopreserved Hepatocytes

Biological Consulting Services

SOP History Number Date Reason for Change v1 10/10/2014 Original V2 10/10/2016 Update V3 10/10/2018 Update

DRAFT. c 2.G Serological diagnosis of influenza by microneutralization assay 2.G

SOME PROPERTIES OF ECHO AND COXSACKIE VIRUSES IN TISSUE CULTURE AND VARIATIONS BY HEAT

Human ipsc-derived Ventricular Cardiomyocytes. Protocol version 3.1

16026 University Oak, San Antonio, TX 78249

Human Induced Plutipotent Stem Cell (ipsc) Handling Protocols: Matrigel and mtesr/e8 Media

L6 GLUT4myc Cell Growth Protocol

1.1. Gelatinizing Plates Prepare plates by covering surface with 0.1% Gelatin solution:

Human Umbilical Vein Endothelial Cell Manual

Cryopreserved HepaRG Cells and Media Supplements

Pluricyte Cardiomyocytes

FOCUS SubCell. For the Enrichment of Subcellular Fractions. (Cat. # ) think proteins! think G-Biosciences

Pandemic Preparedness Team Immunology and Pathogenesis Branch Influenza Division Centers for Disease Control and Prevention USA VERSION 1

ab CytoPainter Golgi/ER Staining Kit

Plaque Assay of Sendai Virus in Monolayers of a Clonal Line

NINDS Repository Human Induced Pluripotent Stem Cell (ipsc) Handling Protocols (Matrigel and mtesr Media)

INSTRUCTIONS Pierce Primary Cardiomyocyte Isolation Kit

Micro haemagglutination test in a V-bottom microwell plate

Norovirus Report. Can copper and silver ionisation kill norovirus? A Study Report

PERSISTENT INFECTIONS WITH HUMAN PARAINFLUENZAVIRUS TYPE 3 IN TWO CELL LINES

Effects of Cell Culture and Laboratory Conditions on Type 2 Dengue Virus Infectivity

Introduction.-Cytopathogenic viruses may lose their cell-destroying capacity

Rhinovirus on Hands. Charlottesville, Virginia Received for publication 25 August to each hand in all experiments.

KENNEL KARE SC DISINFECTANT / CLEANER / DEODORIZER Efficacy Data EPA Reg. #

Interpretation Guide. Enterobacteriaceae Count Plate

ACTG Laboratory Technologist Committee Revised Version 2.0 ACTG Lab Man HIV Syncytium-Inducing (MT-2) assay 29 April 2004

Leukocytes and Interferon in the Host Response to Viral Infections

human Total Cathepsin B Catalog Number: DY2176

Human Mammary Luminal Epithelial Cells. Manual

PEDV Research Updates 2013

SIV p27 ANTIGEN CAPTURE ASSAY

ADCC Assay Protocol Vikram Srivastava 1, Zheng Yang 1, Ivan Fan Ngai Hung 2, Jianqing Xu 3, Bojian Zheng 3 and Mei- Yun Zhang 3*

Mouse Hepatic Progenitor Organoid Culture: Supplementary Protocols

BaculoELISA Titer Kit User Manual

Striatal Neuron Medium Kit

HbA1c (Human) ELISA Kit

Amantadine in Tissue Culture'

Human Thyroid-Peroxidase Antibody, TPO-Ab ELISA Kit

Immature organoids appear after hours.

Human Pluripotent Stem Cell Cardiomyocyte Differentiation Kit (PSCCDK) Introduction Kit Components Cat. # # of vials Reagent Quantity Storage

LDL (Human) ELISA Kit

TEST REPORT. Anti-viral effect of disinfectant against feline calicivirus

WiCell Neural Stem Cell Protocols

CytoPainter Lysosomal Staining Kit - Blue Fluorescence

The Effect of Environment on the Replication of Poliovirus in Monkey Kidney Cells

CHO α 1 β 2 γ 2 GABAA Cell Line

Mechanism of Pock Formation by Shope Fibroma

Host Defense Mechanisms Against Influenza Virus: Interaction of Influenza Virus with Murine Macrophages In Vitro

Freeze-Dried Erythrocytes for an Indirect Hemagglutination Test for Detection of Cytomegalovirus Antibodies

To detect antibodies to Avian Influenza (AI) using the haemagglutination inhibition test in avian serum specimens 2.

Test Report. Test for virus inactivation by a built-in UVC lamp in a bedding cleaner. Issued by KRCES No. 2017_0001 April 21, 2017

Identification of Microbes Lecture: 12

Mouse primary keratinocytes preparation

Constitutive Reporter Lentiviral Vectors Expressing Fluorescent Proteins

Cryopreserved Human Hepatocytes (Cat # HP-F)

Supplementary Figures

Large Scale Infection for Pooled Screens of shrna libraries

TEST REPORT. Test of Viral Inactivation by UVC Lamp Built into Futon Cleaner. KRCES Report No. 2016_0035 November 15, 2016

Effect of Magnesium on Replication of Rhinovirus HGP'

xcelligence Real-Time Cell Analyzers

BY F. BROWN, B. CARTWRIGHT AND DOREEN L. STEWART Research Institute (Animal Virus Diseases), Pirbright, Surrey. (Received 22 August 1962) SUMMARY

Human Keratinocytes. Protocol version 1.0

NF-κB p65 (Phospho-Thr254)

Human HBcAb IgM ELISA kit

(;[rowth Charaeteristies of Influenza Virus Type C in Avian Hosts

NUTRITIONAL REQUIREMENTS FOR THE PRODUCTION OF POLIOVIRUS

KENNEL KARE SC DISINFECTANT / CLEANER / DEODORIZER Efficacy Data EPA Reg. #

Macrophage Generation Media DXF

Procine sphingomyelin ELISA Kit

Inactivation of Adenovirus Type 5, Rotavirus WA and Male Specific Coliphage (MS2) in Biosolids by Lime Stabilization

IN VITRO ANTICANCER ACTIVITY OF FLOWER EXTRACTS OF COUROUPITA GUIANENSIS

Canine Thyroid Stimulating Hormone, TSH ELISA Kit

Human Dermal Microvascular Endothelial Cells. Protocol version 1.0

Transcription:

Final report submitted to Virox Technologies, Inc. EVALUATION OF THE EFFECTIVENESS OF A 7% ACCELERATED HYDROGEN PEROXIDE-BASED FORMULATION AGAINST CANINE PARVOVIRUS Syed A. Sattar, M.Sc., Dip. Bact., M.S., Ph.D., RM (CCM) Professor and Principal Investigator Department of Microbiology and Immunology Faculty of Medicine, University of Ottawa Ottawa, Ontario, Canada K1H 8M5 Phone: (613) 562-5800 ext. 8314 Fax: (613) 562-5452 This study was conducted with the technical assistance of Ms. Sola Adegbunrin, M.Sc., and Ms. Helmalee Karunaratna February, 2004

2 OBJECTIVE OF THE STUDY The objective of this study was to evaluate the activity of a formulation based on 7% accelerated hydrogen peroxide (AHP) against canine parvovirus, using protocol # E1053-97 of ASTM International (ASTM 1997). The Test Product MATERIALS AND METHODS Three lots (3387, 3388 and 3389) of AHP5 were shipped to us directly by the Sponsor. Upon receipt, they were stored at room temperature in an area with controlled access. The product was tested at a dilution of 1:16 in hard water with 200 ppm hard as CACO 3. The product performance criterion was arbitrarily set at a minimum 3log 10 reduction in virus infectivity. The Challenge Virus Canine parvovirus: The canine parvovirus used in this study was the Cornell strain (ATCC VR-2017). The virus was grown and plaque assayed in the A72 line of canine tumor cells. A seed culture of these cells and the virus were kindly provided to us by Ms. Karen Ramm of Viromed Laboratories Inc., Minneapolis, MN. The cells were grown in Eagle s minimal essential medium (MEM; GIBCO-BRL Cat # 41600-016) in the presence of L-glutamine, antibiotics, and 10% fetal bovine serum (FBS) in 75 cm 2 flasks at 37 o C. For preparing the virus pool, 200 L of the viral suspension was inoculated onto a 18-24 hour-old cell monolayer, in a 75 cm 2 cell culture flask containing 1.8mL MEM with 5% FBS. The inoculum was spread evenly over the monolayer by gentle rocking of the flask. The flask was kept at 37 o C for 60 minutes to allow for virus adsorption. Supplemented MEM with 5% FBS was added to the inoculated monolayer and the flask incubated at 37 C for 4-5 days by which time nearly 85% of the cell monolayer showed viral cytopathology. The virus was separated from the cells by three rapid freeze-thaw cycles followed by centrifugation at 2,000 rpm for 5 minutes. The supernatant, which contained the virus, was aspirated and dispensed in aliquots of 1 ml and stored at -80 C. The viral titer was determined by a plaque assay method and was found to be about 2 x 10 5 plaque forming units (PFU)/mL. Organic load No added soil load was used in this testing because the virus pool already contained about 5% FBS. Test Method The test method used in this study is ASTM International s Standard Method for Efficacy of Virucidal Agents Intended for inanimate Environmental Surfaces. Parvovirus suspension (0.2 ml) was spread over the surface of a sterile glass Petri dish with a pipette tip and allowed to air dry for about 15-20 minutes at ambient temperature. The dried virus films were then exposed to 2.0 ml of the disinfectant for the required exposure time at

3 room temperature (23±1 C). Thirty seconds before the end of the contact time, the inoculum was scraped with a rubber policeman and remained in suspension until the end of the contact time. At the end of the contact time the virus/disinfectant mixture was swirled gently to mix in the Petri dish and 0.2 ml from the mixture was transferred into 1.8 ml of Letheen broth + 1% sodium thiosulphate. A control experiment was run in parallel and treated in the same manner except that 2.0 ml of EBSS was used in place of the disinfectant. To remove any cytotoxicity in the neutralized mixture, the neutralized samples were passed through a column of Sephadex LH-20 as described in the ASTM method E1482-92 (ASTM 1992). The filtrates were transferred into sterile labeled dilution vials. The control and test filtrates were serially diluted and inoculated into cell culture monolayer for virus plaque assays. The PFU were determined and log 10 reductions calculated. Cytotoxicity and Interference with Plaque Formation: To determine the effect of the detoxified test product on cell monolayers and the plaque forming ability of the test virus, 1.2 ml of a 1/10 and 1/100 dilution of the test product in neutralizer were first passed through the Sephadex column to remove cytotoxicity. The filtrates were then placed into three wells each of a 12-well cell culture plate while the other six wells received neutralizer which was also passed through the column and EBSS, respectively, as controls and allowed to incubate for 30 minutes. The monolayers were observed under an inverted microscope for signs of toxicity of the test product. In the absence of any apparent cytotoxicity, the monolayers were then washed once with EBSS. Virus, diluted to give countable plaques/well, was added to each well. The virus was allowed to adsorb for 60 minutes. Each cell monolayer was then overlaid with a semisolid overlay and the plates held at 37 o C for the development of virus plaques. Germicide Neutralization Control: This was to determine if the neutralization of the sample, followed by detoxification, was sufficient to render it ineffective against the test virus. The test virus (200 L) was added to 1.8 ml of the neutralized sample (in the ratio of 1:9). The mixture was then passed through a Sephadex column. The same amount of virus was added to 1.8 ml of the neutralizer control. The virus eluates were then inoculated onto cell monolayer, followed by adsorption for 1 hour and subsequent addition of overlay medium and incubation. Plaque Assay Canine Parvovirus: Trypsinized cells from 2-4 day old cultures in 75 cm 2 flasks were seeded in 2 ml volumes in each well of a 12-well cell culture plate. The plates were incubated for 2-4 hrs for the cells to attach. The growth medium from each plate was aspirated and 100 L of the appropriate dilutions of viral suspension was then dispensed directly onto the monolayer. Each dilution was titrated in triplicate. The plates were incubated for 60 min. in a 5% CO 2 incubator after which a 2 ml overlay medium consisting of equal part of McCoy S and L-15 medium containing inhibitor-free 5% FBS and 1% methyl cellulose (Fisher, 4000 centipoises) were added and inoculated plates were incubated at 37 o C in an atmosphere of 5% humidified

4 CO 2 for seven days. The plates were then fixed for at least 3 hours with 3.7% formaldehyde and stained with 0.1% aqueous crystal violet. RESULTS AND DISCUSSION Activity of AHP against the canine parvovirus: As seen in Table 1, a 1/16 dilution of the product was able to bring about a >4 log 10 reduction in the viability titre of the parvovirus in a contact time of 5 minutes at ambient temperature, indicating good virucidal activity against this organism. Table 1: The activity of AHP against Canine parvovirus Date of experiment Lot number contact time PFU/control carrier PFU/test carrier Log 10 Reduction 5/02/04 3387 5 minutes 9.60 x10 4 0 4.90 5/02/04 3388 5 minutes 9.60 x10 4 0 4.90 5/02/04 3389 5 minutes 9.60 x10 4 0 4.90 Cytotoxicity of the Test Product: A 1:10 dilution of the product in the neutralizer, followed by gel filtration, showed no apparent toxicity for the cell line used for the study. Interference with Plaque Formation: Pre-exposure of the cell monolayer to a 1:10 dilution of the test product in the neutralizer, followed by gel filtration, did not interfere with the plaque formation by the virus tested in the study. Any. interference by the residual amounts of the product would have resulted in significantly lower numbers of plaques in the monolayer pretreated with its dilution when compared to the the number of plaques in the control monolayers. Neutralization of the Product to Arrest its Virucidal Activity: Adding the viruses separately to a 1:10 dilution of the product in the neutralizer followed by gel filtration did not result in any loss in their infectivity, which indicates that the neutralization of the test product at the end of the contact time, followed by gel filtration, was sufficient to arrest its virucidal activity. CONCLUDING REMARKS Under the test conditions reported here, Virox 7% Accelerated Hydrogen Peroxide (AHP) at a dilution of 1:16 was able to bring about a >4 log 10 reduction in the viability titre of the canine parvovirus. Pre-exposure of the cell monolayer to a 1:10 dilution of the detoxified test product or a neutralizer did not interfere with the plaque formation by the virus tested in the study. LITERATURE CITED

5 ASTM International (1997): Standard Test Method for Efficacy of Virucidal Agents Intended for Inanimate Environmental Surfaces. Document #E 1053-97. ASTM International, West Conshohocken, PA. ASTM International (1992): Standard Test Method for Neutralization of Virucidal Agents in Virucidal Efficacy Evaluations. Document #E 1482-92. ASTM International, West Conshohocken, PA.